[Form 4] Under Armour, Inc. Insider Trading Activity
Carolyn N. Everson, a director of Under Armour, Inc. (UA), reported a non-derivative acquisition on 10/01/2025 under the company’s Fiscal Year 2025 Non-Employee Director Compensation Plan. The filing shows 1,024.59 Class C common stock units were acquired as deferred stock units at a price of $0. After the transaction, Ms. Everson beneficially owns 106,552.09 shares (Class C), and the filer discloses no beneficial ownership of Class A common stock (UAA). The Form 4 was signed by an attorney-in-fact on 10/02/2025.
- Director compensation was reported transparently as deferred stock units under the company’s Fiscal Year 2025 Non-Employee Director Compensation Plan
- Form 4 includes a clear transaction date (10/01/2025) and a signed filing (10/02/2025), satisfying reporting timeliness and signature disclosure
- Acquisition recorded at $0 reflects issuance via plan rather than purchase, which does not increase outside investor cash flow into the company
- No Class A common stock (UAA) beneficial ownership is reported, indicating holdings are limited to Class C shares which may have different voting/economic implications
Insights
Director deferred compensation converted to 1,024.59 Class C units.
The transaction reflects director compensation paid as deferred stock units under the company’s Fiscal Year 2025 Non-Employee Director Compensation Plan, not an open-market purchase. This is indicated by the Code V transaction code and the $0 price reported.
Because the filing reports 106,552.09 Class C shares owned after the transaction and explicitly states no Class A shares are owned, the holding is concentrated in Class C equity, which may affect voting and economic interest distinctions disclosed by the company.
Form 4 documents a routine, compensatory issuance, properly reported.
The filing lists the transaction date as 10/01/2025 and includes an attorney-in-fact signature dated 10/02/2025, meeting Form 4 procedural requirements. The use of deferred stock units for director fees is disclosed in the explanation section, linking the issuance to the company’s compensation plan rather than market trading.